BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7879025)

  • 21. Suppression of corneal allograft rejection after penetrating keratoplasty by antibodies to ICAM-1 and LFA-1 in mice.
    Yamagami S; Obata H; Tsuru T; Isobe M
    Transplant Proc; 1995 Apr; 27(2):1899-900. PubMed ID: 7725542
    [No Abstract]   [Full Text] [Related]  

  • 22. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
    Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
    Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
    Brendel MD; Schachner RS; Kong SS; Qian T; Alejandro R; Mintz DH
    Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
    [No Abstract]   [Full Text] [Related]  

  • 24. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fish-to-mouse islet xenograft survival is markedly prolonged by 15-deoxyspergualin.
    Wright JR; Kearns H
    Transplant Proc; 1995 Feb; 27(1):294-5. PubMed ID: 7879009
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolongation of allograft survival with Ling Zhi-8, a new immunosuppressive drug.
    van der Hem LG; van der Vliet JA; Bocken CF; Kino K; Hoitsma AJ; Tax WJ
    Transplant Proc; 1994 Apr; 26(2):746. PubMed ID: 8171639
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of an anti-LFA-1 antibody in renal allograft rejection in sheep.
    Grooby WL; Carter JK; Rao MM; Dewan P; Seymour AE; Brandon M; Russ GR
    Transplant Proc; 1992 Oct; 24(5):2304. PubMed ID: 1413070
    [No Abstract]   [Full Text] [Related]  

  • 28. Class I major histocompatibility complex antigen disparity is not a barrier to successful pancreatic islet cell engraftment.
    Jain K; Cai BR; Patel S; Anderson M; Miller D; Smith BH; Rubin AL; Suthanthiran M
    Transplant Proc; 1994 Dec; 26(6):3323-4. PubMed ID: 7998155
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of concordant and discordant xenografted islets of Langerhans rejection.
    Bühler L; Deng S; Andereggen E; Bubloz C; Rohner A; Morel P
    Transplant Proc; 1994 Dec; 26(6):3453-4. PubMed ID: 7998218
    [No Abstract]   [Full Text] [Related]  

  • 30. Local CTLA4Ig synergizes with one-dose anti-LFA-1 to achieve long-term acceptance of pancreatic islet allografts.
    Chahine AA; Yu M; McKernan M; Stoeckert C; Linsley PS; Lau HT
    Transplant Proc; 1994 Dec; 26(6):3296. PubMed ID: 7998139
    [No Abstract]   [Full Text] [Related]  

  • 31. Monotherapy with anti-LFA-1 monoclonal antibody promotes long-term survival of rat islet xenografts.
    Tredget EB; Arefanian H; Gill RG; Rajotte RV; Rayat GR
    Cell Transplant; 2008; 17(6):599-608. PubMed ID: 18819248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of concanavalin A on mouse islet cell transplantation.
    Zhu XY; He J; Yang PA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):954-6. PubMed ID: 3152647
    [No Abstract]   [Full Text] [Related]  

  • 33. Fine specificity of class I MHC recognition in islet allografts.
    Ferguson D; Kohli N; Munn SR
    Transplant Proc; 1995 Dec; 27(6):3222. PubMed ID: 8539924
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolongation of rat islet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1.
    Yang H; Issekutz TB; Wright JR
    Transplantation; 1995 Jul; 60(1):71-6. PubMed ID: 7624946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract]   [Full Text] [Related]  

  • 36. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
    Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunomodulation with ionizing radiation does not prolong fish-to-mouse islet xenograft survival.
    Yang H; Kearns H; Wright JR
    Transplant Proc; 1995 Dec; 27(6):3312-3. PubMed ID: 8539966
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunosuppressive effects of monoclonal antibodies against adhesion molecules in rat pancreas allografts.
    Kawabe A; Suzuki H; Kimura T; Harada Y; Tamatani T; Miyasaka M
    Transplant Proc; 1994 Aug; 26(4):1937-8. PubMed ID: 7915055
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of direct and indirect antigen presentation in the response to islet xenografts.
    Gill RG
    Transplant Proc; 1992 Apr; 24(2):642-3. PubMed ID: 1533075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.